90 related articles for article (PubMed ID: 16025439)
41. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
42. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs.
Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471
[TBL] [Abstract][Full Text] [Related]
43. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
44. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
[TBL] [Abstract][Full Text] [Related]
46. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
47. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
[TBL] [Abstract][Full Text] [Related]
48. Prolonged survival of experimental extremity allografts: a new protocol with total body irradiation, granulocyte-colony stimulation factor, and FK506.
Muramatsu K; Kuriyama R; Kato H; Yoshida Y; Taguchi T
J Orthop Res; 2010 Apr; 28(4):457-61. PubMed ID: 19877287
[TBL] [Abstract][Full Text] [Related]
49. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.
Rahhal DN; Xu H; Huang WC; Wu S; Wen Y; Huang Y; Ildstad ST
Transplantation; 2009 Sep; 88(6):773-81. PubMed ID: 19920776
[TBL] [Abstract][Full Text] [Related]
50. Induction of tolerance in composite-tissue allografts.
Siemionow M; Ortak T; Izycki D; Oke R; Cunningham B; Prajapati R; Zins JE
Transplantation; 2002 Nov; 74(9):1211-7. PubMed ID: 12451256
[TBL] [Abstract][Full Text] [Related]
51. Maintenance of donor-specific chimerism despite osteopontin-associated bone fibrosis in a vascularized bone marrow transplantation model.
Klimczak A; Unal S; Agaoglu G; Carnevale K; Siemionow M
Plast Reconstr Surg; 2009 Feb; 123(2 Suppl):34S-44S. PubMed ID: 19182662
[TBL] [Abstract][Full Text] [Related]
52. Peripheral-nerve allotransplantation in rats immunosuppressed with transient or long-term FK-506.
Weinzweig N; Grindel S; Gonzalez M; Kuy D; Fang J; Shahani B
J Reconstr Microsurg; 1996 Oct; 12(7):451-9. PubMed ID: 8905545
[TBL] [Abstract][Full Text] [Related]
53. Pulsed immunosuppression with everolimus and anti-alphabeta T-cell receptor: laryngeal allograft preservation at six months.
Khariwala SS; Knott PD; Dan O; Klimczak A; Siemionow M; Strome M
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):74-80. PubMed ID: 16466103
[TBL] [Abstract][Full Text] [Related]
54. Rat model of heterotopic toe allotransplantation.
Zhu H; Xie F; Sheng L; Yu Q; Li Q
J Surg Res; 2015 Dec; 199(2):707-17. PubMed ID: 26081004
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction by cyclosporine and tacrolimus.
Wojewodzka J; Galkowska H; Olszewski WL
Transplant Proc; 2003 Sep; 35(6):2376-8. PubMed ID: 14529947
[TBL] [Abstract][Full Text] [Related]
56. Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Busque S; Scandling JD; Lowsky R; Shizuru J; Jensen K; Waters J; Wu HH; Sheehan K; Shori A; Choi O; Pham T; Fernandez Vina MA; Hoppe R; Tamaresis J; Lavori P; Engleman EG; Meyer E; Strober S
Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996467
[TBL] [Abstract][Full Text] [Related]
57. A new total hemiface allotransplantation model in rats.
Kulahci Y; Altuntas SH; Karagoz H; Cwykiel JM; Zor F; Siemionow M
Microsurgery; 2016 Mar; 36(3):230-8. PubMed ID: 26797916
[TBL] [Abstract][Full Text] [Related]
58. The effect of thymus transplantation on donor-specific chimerism in the rat model of composite osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, and skin allotransplantation.
Zor F; Bozkurt M; Cwykiel J; Karagoz H; Kulahci Y; Uygur S; Siemionow M
Microsurgery; 2020 Jul; 40(5):576-584. PubMed ID: 31904149
[TBL] [Abstract][Full Text] [Related]
59. [Experimental studies on vascularized allogeneic joint transplantation in rats].
Muramatsu K
Nihon Seikeigeka Gakkai Zasshi; 1992 Apr; 66(4):315-25. PubMed ID: 1593202
[TBL] [Abstract][Full Text] [Related]
60. Prolonged allograft survival in cynomolgus monkeys treated with a monoclonal antibody to the human type I interferon receptor and low doses of cyclosporine.
Benizri E; Gugenheim J; Lasfar A; Eid P; Blanchard B; Lallemand C; Tovey MG
J Interferon Cytokine Res; 1998 Apr; 18(4):273-84. PubMed ID: 9568730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
